Ferozsons Laboratories Limited (PSX: FEROZ)

Market Cap	12.64B
Revenue (ttm)	15.14B
Net Income (ttm)	493.87M
Shares Out	43.47M
EPS (ttm)	11.36
PE Ratio	25.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	550,784
Open	302.99
Previous Close	299.08
Day's Range	288.10 - 309.99
52-Week Range	135.00 - 323.99
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2024

About Ferozsons Laboratories

Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan and internationally. The company offers products in various therapeutic areas of anti-fungal, diabetes, anti-viral, cardiometabolic, cough, dermatology, orthopaedic, urology and nephrology, gastrointestinal and liver, antibiotics, and oncology areas. It also provides medical devices in the areas of cardiology, G.I. endoscopy, oncology, peripheral vascular disease, urology, a...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1954
• Employees: 1,680
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: FEROZ

Financial Performance

In 2023, Ferozsons Laboratories's revenue was 11.46 billion, an increase of 22.80% compared to the previous year's 9.33 billion. Earnings were 271.27 million, a decrease of -63.06%.